Moderna says FDA needs more time to complete review of its COVID-19 shot for adolescents
Moderna Inc said on Sunday it has been told that the US Food and Drug Administration will require additional time to complete its assessment of the company's COVID-19 vaccine for use in adolescents aged 12 to 17 years.
from bdnews24.com - Home https://ift.tt/3GCOC6I
from bdnews24.com - Home https://ift.tt/3GCOC6I
No comments